EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
-4.98%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$50.7M
AUM Growth
+$50.7M
(-64%)
Cap. Flow
-$86M
Cap. Flow
% of AUM
-169.67%
Top 10 Holdings %
Top 10 Hldgs %
89.73%
Holding
46
New
–
Increased
–
Reduced
17
Closed
27
Top Buys
No buys this quarter
Top Sells
| 1 |
JD.com
JD
|
$12M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
$5.3M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$4.01M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$3.21M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.16M |
Sector Composition
| 1 | Financials | 61.49% |
| 2 | Healthcare | 34.13% |
| 3 | Industrials | 1.88% |
| 4 | Energy | 0.67% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $31.2M | 61.49% |
100
-17
| -15% | -$5.3M |
|
|
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.44M | 4.81% |
67,753
-16,083
| -19% | -$578K |
|
|
THOR
3
DELISTED
Synthorx, Inc. Common Stock
THOR
| $2.36M | 4.66% |
145,150
-5,898
| -4% | -$96K |
|
4
Wave Life Sciences
WVE
$1.53B
| $1.61M | 3.17% |
78,212
-16,263
| -17% | -$334K |
|
5
Rhythm Pharmaceuticals
RYTM
$6.85B
| $1.55M | 3.06% |
71,856
-14,352
| -17% | -$310K |
|
|
RARX
6
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.41M | 2.78% |
59,690
-38,226
| -39% | -$904K |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.38M | 2.71% |
479,902
-165,681
| -26% | -$475K |
|
8
MeiraGTx Holdings
MGTX
$587M
| $1.3M | 2.55% |
81,176
-14,286
| -15% | -$228K |
|
|
ORTX
9
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.29M | 2.55% |
108,692
-14,708
| -12% | -$175K |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $997K | 1.97% |
24,890
-35,015
| -58% | -$1.4M |
|
11
Arcosa
ACA
$4.85B
| $955K | 1.88% |
27,923
-24,341
| -47% | -$832K |
|
12
Heron Therapeutics
HRTX
$207M
| $925K | 1.82% |
49,974
-79,046
| -61% | -$1.46M |
|
13
Travere Therapeutics
TVTX
$1.56B
| $895K | 1.76% |
77,180
-46,420
| -38% | -$538K |
|
|
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
| $762K | 1.5% |
146,475
-31,513
| -18% | -$164K |
|
|
GHDX
15
DELISTED
Genomic Health, Inc.
GHDX
| $645K | 1.27% |
9,506
-33,460
| -78% | -$2.27M |
|
|
SMC
16
Summit Midstream Corporation
SMC
$282M
| $342K | 0.67% |
70,456
-17,104
| -20% | -$83K |
|
17
Cocrystal Pharma
COCP
$15.4M
| $312K | 0.62% |
152,916
| – | – |
|
18
SPDR S&P 500 ETF Trust
SPY
$658B
| $280K | 0.55% |
942
| – | – |
|
19
InflaRx
IFRX
$108M
| $91K | 0.18% |
36,818
-21,631
| -37% | -$53.5K |
|
20
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-90,188
| Closed | -$2.41M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| – | – |
-132,255
| Closed | -$2.56M |
|
22
Ascendis Pharma
ASND
$11.8B
| – | – |
-18,334
| Closed | -$2.11M |
|
23
Bread Financial
BFH
$3.09B
| – | – |
-13,028
| Closed | -$1.83M |
|
24
Bausch Health
BHC
$2.74B
| – | – |
-78,121
| Closed | -$1.97M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-26,278
| Closed | -$2.25M |
|